Capital Evolution

At Sun, we remain committed to creating long term value for our shareholders. In line with this philosophy, we will continue to focus on performance and producing consistent returns.

Capital Evolution

Search:

Date of Allotment	No. of equity shares issued	Face Value (Rs.)	Type of Issue	Cumulative capital (No. of equity shares)
01 March 1993	200,000	10.00	Conversion of Partnership Firm	200,000
30 March 1993	700,000	10.00	Cash	900,000
18 September 1993	5,100,000	10.00	Cash	6,000,000
10 November 1993	1,000,000	10.00	Rights Issue	7,000,000
08 January 1994	185,000	10.00	Cash	7,185,000
01 June 1994	3,592,500	10.00	Bonus Issue (in the ratio 1:2)	10,777,500
09 August 1994	323,400	10.00	Rights Issue	11,100,900
08 December 1994	3,700,300	10.00	Public Issue	14,801,200
07 February 1998	413,633	10.00	Allotment pursuant to amalgamation of Tamilnadu Dadha Pharmaceuticals Ltd. (in the ratio of 1:4)	15,214,833
25 March 1999	208,000	10.00	Allotment pursuant to amalgamation of Milmet Laboratories Private Limited (in the ratio of 4:5)	15,422,833
01 April 2000	30,844,466	10.00	Bonus Issue (in the ratio 2:1)	46,267,299
06 June 2000	477,581	10.00	Allotment pursuant to amalgamation of Gujarat Lyka Organics Limited (In the ratio of 1:21.33)	46,744,880
16 January 2001	11,438	10.00	Allotment pursuant to amalgamation of Sun Pharmaceutical Exports Limited (in the ratio of 4:5)	46,756,318
16 January 2001	200	10.00	Bonus (kept in abeyance)	46,756,518
22 March 2001	-500	10.00	Forfeited by the Board of Directors at their Board Meeting held on 22.03.2001	46,756,018
30 March 2002	18,519	10.00	Allotment pursuant to amalgamation of Pradeep Drug Company Limited (in the ratio of 1:500)	46,774,537
28 August 2002	19,771	10.00	Allotment pursuant to amalgamation of M. J. Pharmaceuticals Limited (in the ratio of 1:210)	46,794,308
21 January 2003	93,588,616	5.00	Sub-division/split of existing equity shares of Rs.10 each into two equity shares of Rs.5 each	93,588,616
15 March 2003	-209,000	5.00	Shares bought back destroyed	93,379,616
28 March 2003	-156,838	5.00	Shares bought back destroyed	93,222,778
16 April 2003	-174,300	5.00	Shares bought back destroyed	93,048,478
08 May 2003	-262,732	5.00	Shares bought back destroyed	92,785,746
23 May 2003	-30,068	5.00	Shares bought back destroyed	92,755,678
08 June 2004	92,755,678	5.00	Bonus Issue (in the ratio 1:1)	185,511,356
18 August 2005	4,274	5.00	Allotment pursuant to amalgamation of Phlox Pharmaceuticals Limited (in the ratio of 1:790)	185,515,630
31 March 2006	216,007	5.00	Allotment against conversion of FCCBs	185,731,637
22 April 2006	154,291	5.00	Allotment against conversion of FCCBs	185,885,928
16 May 2006	61,716	5.00	Allotment against conversion of FCCBs	185,947,644
07 June 2006	58,445	5.00	Allotment against conversion of FCCBs	186,006,089
14 June 2006	61,716	5.00	Allotment against conversion of FCCBs	186,067,805
04 September 2006	30,858	5.00	Allotment against conversion of FCCBs	186,098,663
13 September 2006	98,746	5.00	Allotment against conversion of FCCBs	186,197,409
16 September 2006	462,875	5.00	Allotment against conversion of FCCBs	186,660,284
09 October 2006	306,668	5.00	Allotment against conversion of FCCBs	186,966,952
11 October 2006	61,716	5.00	Allotment against conversion of FCCBs	187,028,668
06 November 2006	262,293	5.00	Allotment against conversion of FCCBs	187,290,961
18 November 2006	50,916	5.00	Allotment against conversion of FCCBs	187,341,877
20 November 2006	462,875	5.00	Allotment against conversion of FCCBs	187,804,752
05 December 2006	828,540	5.00	Allotment against conversion of FCCBs	188,633,292
06 December 2006	185,150	5.00	Allotment against conversion of FCCBs	188,818,442
18 December 2006	1,238,648	5.00	Allotment against conversion of FCCBs	190,057,090
09 January 2007	299,324	5.00	Allotment against conversion of FCCBs	190,356,414
18 January 2007	706,654	5.00	Allotment against conversion of FCCBs	191,063,068
19 January 2007	216,008	5.00	Allotment against conversion of FCCBs	191,279,076
03 February 2007	623,333	5.00	Allotment against conversion of FCCBs	191,902,409
22 February 2007	222,179	5.00	Allotment against conversion of FCCBs	192,124,588
23 February 2007	135,467	5.00	Allotment against conversion of FCCBs	192,260,055
09 March 2007	277,725	5.00	Allotment against conversion of FCCBs	192,537,780
31 March 2007	864,340	5.00	Allotment against conversion of FCCBs	193,402,120
21 April 2007	1,016,778	5.00	Allotment against conversion of FCCBs	194,418,898
19 May 2007	518,417	5.00	Allotment against conversion of FCCBs	194,937,315
09 June 2007	1,139,901	5.00	Allotment against conversion of FCCBs	196,077,216
28 June 2007	1,018,323	5.00	Allotment against conversion of FCCBs	197,095,539
21 July 2007	842,430	5.00	Allotment against conversion of FCCBs	197,937,969
11 August 2007	1,247,972	5.00	Allotment against conversion of FCCBs	199,185,941
14 October 2007	339,441	5.00	Allotment against conversion of FCCBs	199,525,382
20 October 2007	864,034	5.00	Allotment against conversion of FCCBs	200,389,416
03 November 2007	509,161	5.00	Allotment against conversion of FCCBs	200,898,577
01 December 2007	208,599	5.00	Allotment against conversion of FCCBs	201,107,176
29 December 2007	339,439	5.00	Allotment against conversion of FCCBs	201,446,615
25 January 2008	30,858	5.00	Allotment against conversion of FCCBs	201,477,473
01 March 2008	3,120,084	5.00	Allotment against conversion of FCCBs	204,597,557
20 March 2008	2,518,834	5.00	Allotment against conversion of FCCBs	207,116,391
29 November 2010	1,035,581,955	1.00	Sub-division/split of existing equity shares of Rs.5 each into five equity shares of Re.1 each	1,035,581,955
03 August 2013	1,035,581,955	1.00	Bonus Issue (in the ratio 1:1)	2,071,163,910
10 April 2015	334,956,764	1.00	Allotment pursuant to amalgamation of Ranbaxy Laboratories Limited (in the ratio of 8:10)	2,406,120,674
29 April 2015	21,864	1.00	Shares allotted under ESOS	2,406,142,538
29 April 2015	63,396	1.00	Shares allotted under ESOS	2,406,205,934
29 April 2015	44,509	1.00	Shares allotted under ESOS	2,406,250,443
29 April 2015	17,136	1.00	Shares allotted under ESOS	2,406,267,579
29 April 2015	143,769	1.00	Shares allotted under ESOS	2,406,411,348
29 April 2015	12,000	1.00	Shares allotted under ESOS	2,406,423,348
23 July 2015	12,492	1.00	Shares allotted under ESOS	2,406,435,840
23 July 2015	18,128	1.00	Shares allotted under ESOS	2,406,453,968
23 July 2015	11,404	1.00	Shares allotted under ESOS	2,406,465,372
23 July 2015	8,244	1.00	Shares allotted under ESOS	2,406,473,616
23 July 2015	22,521	1.00	Shares allotted under ESOS	2,406,496,137
31 October 2015	8,432	1.00	Shares allotted under ESOS	2,406,504,569
31 October 2015	7,114	1.00	Shares allotted under ESOS	2,406,511,683
31 October 2015	6,300	1.00	Shares allotted under ESOS	2,406,517,983
31 October 2015	5,328	1.00	Shares allotted under ESOS	2,406,523,311
31 October 2015	12,739	1.00	Shares allotted under ESOS	2,406,536,050
31 October 2015	130,000	1.00	Shares allotted under ESOP	2,406,666,050
12 February 2016	16,973	1.00	Shares allotted under ESOS	2,406,683,023
12 February 2016	3,576	1.00	Shares allotted under ESOS	2,406,686,599
12 February 2016	3,912	1.00	Shares allotted under ESOS	2,406,690,511
12 February 2016	2,304	1.00	Shares allotted under ESOS	2,406,692,815
12 February 2016	5,684	1.00	Shares allotted under ESOS	2,406,698,499
12 February 2016	30,000	1.00	Shares allotted under ESOP	2,406,728,499
02 May 2016	3,950	1.00	Shares allotted under ESOS	2,406,732,449
02 May 2016	2,958	1.00	Shares allotted under ESOS	2,406,735,407
02 May 2016	3,708	1.00	Shares allotted under ESOS	2,406,739,115
02 May 2016	14,844	1.00	Shares allotted under ESOS	2,406,753,959
21 October 2016	-7,500,000	1.00	Shares bought back destroyed	2,399,253,959
22 November 2016	4,780	1.00	Shares allotted under ESOS	2,399,258,739
22 November 2016	3,404	1.00	Shares allotted under ESOS	2,399,262,143
22 November 2016	2,340	1.00	Shares allotted under ESOS	2,399,264,483
22 November 2016	5,705	1.00	Shares allotted under ESOS	2,399,270,188
14 February 2017	11,334	1.00	Shares allotted under ESOS	2,399,281,522
14 February 2017	3,026	1.00	Shares allotted under ESOS	2,399,284,548
14 February 2017	3,233	1.00	Shares allotted under ESOS	2,399,287,781
14 February 2017	3,400	1.00	Shares allotted under ESOS	2,399,291,181
26 May 2017	1,560	1.00	Shares allotted under ESOS	2,399,292,741
26 May 2017	360	1.00	Shares allotted under ESOS	2,399,293,101
26 May 2017	1,080	1.00	Shares allotted under ESOS	2,399,294,181
26 May 2017	12,000	1.00	Shares allotted under ESOP	2,399,306,181
11 August 2017	244	1.00	Shares allotted under ESOS	2,399,306,425
11 August 2017	180	1.00	Shares allotted under ESOS	2,399,306,605
11 August 2017	375	1.00	Shares allotted under ESOS	2,399,306,980
26 September 2017	1,106	1.00	Shares allotted under ESOP	2,399,308,086
14 November 2017	1,260	1.00	Shares allotted under ESOS	2,399,309,346
14 February 2018	12,652	1.00	Shares allotted under ESOS	2,399,321,998
14 February 2018	792	1.00	Shares allotted under ESOS	2,399,322,790
14 February 2018	390	1.00	Shares allotted under ESOS	2,399,323,180
24 May 2018	720	1.00	Shares allotted under ESOS	2,399,323,900
24 May 2018	594	1.00	Shares allotted under ESOS	2,399,324,494
13 August 2018	180	1.00	Shares allotted under ESOS	2,399,324,674
12 November 2018	2,160	1.00	Shares allotted under ESOS	2,399,326,834
12 November 2018	1,440	1.00	Shares allotted under ESOS	2,399,328,274
11 February 2019	6,696	1.00	Shares allotted under ESOS	2,399,334,970

Showing 1 to 120 of 120 entries

Note :
Shares allotted under ESOS – Allotment under Sun Employee Stock Option Scheme -2015 to employees
Shares allotted under ESOP – Allotment under Sun Employee Stock Option Plan -2015 to Sun Pharma ESOP Trust for allocation to employees